Cellebrite (CLBT) reported Q1 adjusted earnings Thursday of $0.12 per diluted share, compared with $0.10 a year earlier.

Analysts surveyed by FactSet expected $0.10.

Revenue for the quarter ended March 31 was $128.3 million, compared with $107.5 million a year earlier.

Analysts surveyed by FactSet expected $127 million.

The company expects Q2 revenue of $130 million to $133 million, and 2026 revenue of $565 million to $571 million.

Analysts polled by FactSet expect Q2 and 2026 revenue of $135 million and $568.5 million, respectively.

Shares of Cellebrite were down more than 4% pre-bell.